European Markets Poised for Mixed Open as Germany Initiates Uniper Privatization New York Magazine Investigates Plagiarism Allegations Against Writer Potential Fallout for Publishing and Media Trust ESS Tech GWH Stock Down 209 Support Test at 080 20260519 Savara SVRA Q1 2026 Results Fall Short EPS 015 Revenue NA Hedge Funds Book Profits Following Surge in Semiconductor Stocks Charles Schwab Analyst Report Highlights Potential Impact of Interest Rate Environment Novo Nordisk Eyes Global Expansion as Wegovy Pill Gains Traction in US Market Somnigroup International SGI Q1 2026 Earnings Surprise EPS 059 Up Significant CapitaLand Unveils 14 Billion Life Sciences Hub Geneo to Transform Science Park Jim Cramer Advises Investors to Focus on Upside Potential Not Past Stock Performance NASA Selects Blue Origin for Initial Uncrewed Lunar Mission in 20 Billion Moon Base Effort Qualcomm Gains Momentum as Investor Sentiment Shifts Toward AI Device Boom Your Bond Portfolio May Be Facing a Termite Infestation Worse Than Jamie Dimons Cockroaches Ultralife Corp Director Bradford Whitmore Acquires 715313 in Company Shares Wayfair Q1 2026 Earnings EPS Slightly Misses Estimates Amid Ongoing Market Challenges FCAP Q1 2026 Earnings EPS of 130 Highlights Cost Discipline Amid Modest Operating Environment NKTX Q1 2026 Earnings Narrowing Loss and Stable Stock Performance CRM Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Lower Cresud Q1 2026 Earnings Strong EPS of 61402 Amid No Revenue Detail Stock Rises 286 IEA Chief Warns Oil Markets Approaching Red Zone as Iran Crisis Intensifies INNV Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines European Stocks Open Higher as Markets Eye Potential Progress in Iran Nuclear Talks FRBA Q1 2026 Earnings EPS Misses Estimates by Wide Margin Despite Positive Stock Reaction Immatics NV IMTX Q1 2026 Earnings WiderThanExpected Loss Amid Clinical Progress Adagene Q2 2025 Earnings Clinical Progress Overshadows EPS Miss Shares Jump Should You Take Social Security Early and Switch to Survivor Benefits Later A Case Study at 62 TVTX Q1 2026 Earnings EPS Misses Estimates as Clinical Costs Weigh on Results Stock Surges 78